CARINNE CARDONA: Open Payments
NPI 1306554027 · RONKONKOMA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,714 in 69 payments from 16 companies in 2025. Trend: 2023 $1,770 · 2024 $1,903 · 2025 $1,714
Food & beverage: $1,714
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $436 |
| HARMONY BIOSCIENCES LLC | 6 | $184 |
| Lundbeck LLC | 7 | $159 |
| ARGENX US, INC. | 5 | $154 |
| Supernus Pharmaceuticals, Inc. | 5 | $144 |
| UCB, Inc. | 5 | $110 |
| Lilly USA, LLC | 4 | $97 |
| Amneal Pharmaceuticals LLC | 3 | $76 |
| SCILEX PHARMACEUTICALS INC. | 3 | $69 |
| Axsome Therapeutics, Inc. | 3 | $64 |
Products named: UBRELVY, QULIPTA, WAKIX, VYEPTI, Qelbree, VYVGART, Briviact, CREXONT.
Industry payments across NY — which companies pay providers there.
